• Return to Headlines

Shares of Eli Lilly & Co Rise Above Previous 52-Week High

By Amy Schwartz

Eli Lilly & Co (NYSE:LLY) traded today at a new 52-week high of $89.19. This new high was reached on below average trading volume as 427,000 shares traded hands, while the average 30-day volume is approximately 3.4 million shares.

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.

There is potential upside of 4.3% for shares of Eli Lilly & Co based on a current price of $89.02 and an average consensus analyst price target of $92.84. Eli Lilly & Co shares have support at the 50-day moving average (MA) of $84.17 and additional support at the 200-day MA of $82.83.

In the past 52 weeks, shares of Eli Lilly & Co have traded between a low of $73.69 and a high of $89.19 and are now at $89.02, which is 21% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has remained constant.

SmarTrend is tracking the current trend status for Eli Lilly & Co and will alert subscribers who have LLY in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows eli lilly & co

Ticker(s): LLY